Aura Biosciences is a biotechnology company developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed.

Register for Details

For more details on financing and valuation for Aura Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Aura Biosciences

Forge green plus iconForge green minus icon

What is Aura Biosciences's IPO price?

Aura Biosciences's IPO price is $7.74 as of 1/18/24.
Forge green plus iconForge green minus icon

What is Aura Biosciences's funding to date?

Aura Biosciences has raised $225.08MM to date.
Forge green plus iconForge green minus icon

When was Aura Biosciences founded?

Aura Biosciences was founded in 2009.

Aura Biosciences Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
3/22/2021 Series E $80.48MM raised $XXX.XX $XXX.XX
7/9/2020 Series D-2 $17MM raised $XXX.XX $XXX.XX
4/2/2019 Series D-1 $40MM raised $XXX.XX $XXX.XX
12/21/2017 Series C-1 and C-2 $42.41MM raised $XXX.XX $XXX.XX
3/5/2015 Series B $28.21MM raised $XXX.XX $XXX.XX
8/17/2014 Series A-2 $5.37MM raised $XXX.XX $XXX.XX
7/4/2013 Series A-1 $8.2MM raised $XXX.XX $XXX.XX
8/26/2011 Series A $3.4MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: May 23, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.